AtriCure, Inc. vs. ResMed Inc.
ResMed Inc. (RMD) comes out ahead, leading on 7 of 9 compared factors.
Size & Scale
| ATRC | RMD | |
|---|---|---|
| Market Cap | $2.91 billion | $32.93 billion |
| Revenue (TTM) | $569.62 million | $5.65 billion |
| Net Income (TTM) | $10.55 million | $1.52 billion |
RMD leads on 3 of 3 size & scale factors.
Valuation
| ATRC | RMD | |
|---|---|---|
| P/E Ratio | 279.43 | 21.90 |
| Price / Book | 5.63 | 5.00 |
| Price / Sales | 5.10 | 5.82 |
RMD leads on 2 of 3 valuation factors.
Profitability
| ATRC | RMD | |
|---|---|---|
| Net Margin | 1.85% | 26.94% |
| Return on Equity | 2.04% | 23.13% |
RMD leads on 2 of 2 profitability factors.
Dividend
| ATRC | RMD | |
|---|---|---|
| Dividend Yield | — | 1.16% |
| Payout Ratio | — | 25.31 |
ATRC and RMD split the dividend factors evenly.
Risk & Sentiment
| ATRC | RMD | |
|---|---|---|
| Short Interest | 3.87% | 4.04% |
ATRC leads on 1 of 1 risk & sentiment factors.
Dig deeper: ATRC overview, ATRC financials, RMD overview, RMD financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.